Related references
Note: Only part of the references are listed.Covalent Fragment Screening Identifies Rgl2 RalGEF Cysteine for Targeted Covalent Inhibition of Ral GTPase Activation
Khuchtumur Bum-Erdene et al.
CHEMMEDCHEM (2022)
CuBr-promoted domino Biginelli reaction for the diastereoselective synthesis of bridged polyheterocycles: Mechanism studies and in vitro anti-tumor activities
Mengting Zeng et al.
CHINESE CHEMICAL LETTERS (2022)
Synthetic approaches and structural diversity of triazolylbutanols derived from voriconazole in the antifungal drug development
Elham Ghobadi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Benchmarking Cleavable Biotin Tags for Peptide-Centric Chemoproteomics
Zongmin Li et al.
JOURNAL OF PROTEOME RESEARCH (2022)
Quantitative Site-Specific Chemoproteomic Profiling of Protein Lipoylation
Shuchang Lai et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)
General Pharmacological Activation Mechanism of K+ Channels Bypassing Channel Gates
Shijie Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Chemoproteomic Profiling of an Ibrutinib Analogue Reveals its Unexpected Role in DNA Damage Repair
Zi Ye et al.
CHEMBIOCHEM (2021)
Proximity-Dependent Labeling of Cysteines
Sudeshna Sen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Lessons in Organic Fluorescent Probe Discovery
Sachin B. Wagh et al.
CHEMBIOCHEM (2021)
A targeted covalent inhibitor of p97 with proteome-wide selectivity
Zi Ye et al.
Acta Pharmaceutica Sinica B (2021)
Recent advances in activity-based probes (ABPs) and affinity-based probes (AfBPs) for profiling of enzymes
Haixiao Fang et al.
CHEMICAL SCIENCE (2021)
Quantitative Proteomics Reveals Cellular Off-Targets of a DDR1 Inhibitor
Jiaqian Xu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Rationally Designed Small-Molecule Inhibitors Targeting an Unconventional Pocket on the TLR8 Protein-Protein Interface
Shuangshuang Jiang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Cellular thermal shift assay for the identification of drug-target interactions in the Plasmodium falciparum proteome
Jerzy Michal Dziekan et al.
NATURE PROTOCOLS (2020)
Discovery of a Potent and Selective Covalent Inhibitor and Activity-Based Probe for the Deubiquitylating Enzyme UCHL1, with Antifibrotic Activity
Nattawadee Panyain et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
Alice Douangamath et al.
NATURE COMMUNICATIONS (2020)
Activity- and reactivity-based proteomics: Recent technological advances and applications in drug discovery
Henry James Benns et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2020)
Rapid Covalent-Probe Discovery by Electrophile-Fragment Screening
Efrat Resnick et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Lysine-Targeted Inhibitors and Chemoproteomic Probes
Adolfo Cuesta et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 88 (2019)
Synthesis and Target Identification of a Novel Electrophilic Warhead, 2-Chloromethylquinoline
Feng Ni et al.
BIOCHEMISTRY (2019)
Fragment-Based Covalent Ligand Screening Enables Rapid Discovery of Inhibitors for the RBR E3 Ubiquitin Ligase HOIP
Henrik Johansson et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Selective and reversible modification of kinase cysteines with chlorofluoroacetamides
Naoya Shindo et al.
NATURE CHEMICAL BIOLOGY (2019)
Synthesis of Novel Derivatives of 1,2,4-Triazoles
Armen S. Galstyan et al.
CHEMISTRYSELECT (2018)
Covalent Modulators of the Vacuolar ATPase
Ying-Chu Chen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Chemoproteomics-Enabled Discovery of a Potent and Selective Inhibitor of the DNA Repair Protein MGMT
Chao Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Development of Specific, Irreversible Inhibitors for a Receptor Tyrosine Kinase EphB3
Alvin Kung et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Proteome-wide covalent ligand discovery in native biological systems
Keriann M. Backus et al.
NATURE (2016)
Donvenient Access to 1,3-Dimethyl[1,2,4]Triazolo[3,4-b][1,3,4]-Thiadiazol-1-Ium and 7H-[1,2,4]Triazolo[4,3-b][1,2,4]Triazol-1-Ium Salts
Mohsen Nikpour et al.
CHEMISTRY OF HETEROCYCLIC COMPOUNDS (2015)
Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies
Renato A. Bauer
DRUG DISCOVERY TODAY (2015)
Tracking cancer drugs in living cells by thermal profiling of the proteome
Mikhail M. Savitski et al.
SCIENCE (2014)
AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
Darren A. E. Cross et al.
CANCER DISCOVERY (2014)
Synthesis and biological activities of some novel aminomethyl derivatives of 4-substituted-5-(2-thienyl)-2,4-dihydro-3H-1,2,4-triazole-3-thiones
Metin Koparir et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Synthesis and in vitro activity of 1,2,4-triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteria
Tomasz Plech et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Alkylsulfanyl-1,2,4-triazoles, a New Class of Allosteric Valosine Containing Protein Inhibitors. Synthesis and Structure-Activity Relationships
Paolo Polucci et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Duocarmycin Analogues Target Aldehyde Dehydrogenase 1 in Lung Cancer Cells
Tanja Wirth et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Measurement and Estimation of Electrophilic Reactivity for Predictive Toxicology
Johannes A. H. Schwoebel et al.
CHEMICAL REVIEWS (2011)
The resurgence of covalent drugs
Juswinder Singh et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Covalent Modifiers: An Orthogonal Approach to Drug Design
Michele H. Potashman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Synthetic approaches towards the sulfonamide substituted-4,5-diaryl-4H-1,2,4-triazole-3-thiones
Latifeh Navidpour et al.
JOURNAL OF HETEROCYCLIC CHEMISTRY (2007)
1,2,4-triazolo mercapto and aminonitriles as potent antifungal agents
X Collin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)